Trump rewriting this federal regulation could unlock billions for the US economy — here’s what investors need to know before laying down serious green
While no investment is without risks, cannabis is inherently risky because it’s not a mature industry. Reclassification could unlock billions, but the timeline for federal legalization or banking …
Democratic House Members Reintroduce Comprehensive Marijuana Legalization Bill [FEATURE]
Passage of the MORE Act would end the discrepancy between federal pot prohibition and the increasingly relaxed attitude toward marijuana in the states. Some 24 states — constituting more than half …
If You’d Invested $1,000 in CRLBF 5 Years Ago, Here’s How Much You’d Have Today
To say you’d have less is understating the severity of the situation. Being charitable, however, all marijuana industry players are struggling with current conditions. As a result, Cresco and its …
Why Curaleaf Stock Flopped on Friday
Such setbacks as Sessions’ effort threaten to move Curaleaf and its peers further out from the goalpost. The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best …
3 Cannabis Stocks to Watch After Trump’s Marijuana Rescheduling Signal
Although the cannabis sector has been in a prolonged slump over the last few years due to the absence of federal reforms, President Trump’s recent comments on marijuana rescheduling have reignited …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Cannabis Stocks Are Roaring 20% Higher This Morning. Here’s Why
Key Points Cannabis stocks once soared to billion-dollar valuations, but now trade at penny stock levels after the hype faded. 40 U.S. states allow medical marijuana, 24 permit recreational use, yet …
Here’s Why JAZZ Stock Is an Unconventional Cannabis Investment
Jazz Pharma is redefining cannabis investing with Epidiolex, a fast-growing FDA-approved epilepsy drug fueling its growth.
Why Curaleaf Stock Was Smoking the Market Today
Now, it’s worth noting Stock Advisor’s total average return is 1,079% — a market-crushing outperformance compared to 191% for the S&P 500. Don’t miss out on the latest top 10 list, available when you …
Have Cannabis Stocks Totally Gone Up in Smoke?
Let’s dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in this space. The post Have Cannabis Stocks Totally Gone Up in Smoke?
Major reforms to medical marijuana program become law
The new law will make it easier and cheaper to get a medical cannabis card by legalizing telehealth consultation with a doctor or advanced practice registered nurse, setting a formula to cap fees on …
As Trump looks at reclassifying cannabis, NH governor says state law won’t change
President Donald Trump is signaling that potential changes could be coming on cannabis at the federal level, but Gov. Kelly Ayotte said any developments in Washington wouldn’t change her outlook on …
Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative
Tilray surges 92% in 3 days amid marijuana rescheduling buzz. Discover how this impacts cannabis stocks and potential investor opportunities.
Why Curaleaf Stock Rocked the Market Today
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182 % for the S&P 500. Don’t miss out on the latest top 10 list, available when you …
Rescheduling Should Send MJ And MSOS Sky High
Cannabis ETFs MJ and MSOS are surging on rescheduling speculation that Trump will reclassify marijuana as a Schedule III drug. Read why I rate them as Buy.
Recent Comments